Takeda et al. (3) examined KISS1 and KISS1R expression in 151 bladder cancer patients to determine their prognostic significance and reported that KISS1 immunoreactivity was significantly decreased in advanced stages of bladder cancer and inversely associated with tumor grade and stage. Here, KISS1 is linked to urinary bladder cancer.